Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican‑3‑derived peptide
about
Trial Watch: Peptide-based anticancer vaccines.Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes.Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells.Trial Watch: Peptide vaccines in cancer therapy.Cancer Immunotherapy Targeted Glypican-3 or Neoantigens.
P2860
Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican‑3‑derived peptide
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Analysis of cytotoxic T lympho ...... h a glypican‑3‑derived peptide
@en
Analysis of cytotoxic T lympho ...... a glypican‑3‑derived peptide.
@nl
type
label
Analysis of cytotoxic T lympho ...... h a glypican‑3‑derived peptide
@en
Analysis of cytotoxic T lympho ...... a glypican‑3‑derived peptide.
@nl
prefLabel
Analysis of cytotoxic T lympho ...... h a glypican‑3‑derived peptide
@en
Analysis of cytotoxic T lympho ...... a glypican‑3‑derived peptide.
@nl
P2093
P2860
P356
P1476
Analysis of cytotoxic T lympho ...... h a glypican‑3‑derived peptide
@en
P2093
Daisuke Nobuoka
Hirofumi Shirakawa
Manami Shimomura
Mayuko Sakai
Tetsuya Nakatsura
Toshiaki Yoshikawa
Yoshitaka Tada
P2860
P304
P356
10.3892/IJO.2013.2044
P577
2013-07-31T00:00:00Z